Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 1848-1853

  Jeong, Hae Chang ^a   Ahn, Youngkeun ^a   Hong, Young Joon ^a   Kim, Ju Han ^a   Jeong, Myung Ho ^a   Kim, Young Jo ^b   Chae, Shung Chull ^c   Cho, Myeong Chan ^d  

^a Chonnam National University Medical School   (South Korea)

^b Young Nam University Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Chungbuk National University Hospital   (South Korea)

Author keywords

Inflammation; Myocardial infarction; Statins; Stents; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; STENT THROMBOSIS;

INFLAMMATION; MYOCARDIAL INFARCTION; STATINS; STENTS; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; STENTS; THROMBOSIS;

EID: 84883292827     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.123     Document Type: Article

References (21)

1. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study Lancet 369 2007 667 678
2. F.G. Welt, and C. Rogers Inflammation and restenosis in the stent era Arterioscler Thromb Vasc Biol 22 2002 1769 1776
3. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
4. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
5. D.W. Park, S.C. Yun, and J.Y. Lee C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation Circulation 120 2009 1987 1995
6. A. Schomig, J. Mehilli, and H. Holle Statin treatment following coronary artery stenting and one-year survival J Am Coll Cardiol 40 2002 854 861
7. M. Settergren, F. Bohm, L. Ryden, and J. Pernow Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease Eur Heart J 29 2008 1753 1760
8. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein N Engl J Med 359 2008 2195 2207
9. E.Y. Yang, V. Nambi, and Z. Tang Clinical implications of jupiter (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin) in a U.S. Population insights from the aric (atherosclerosis risk in communities) study J Am Coll Cardiol 54 2009 2388 2395
10. K. Goel, R.J. Lennon, R.T. Tilbury, R.W. Squires, and R.J. Thomas Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community Circulation 123 2011 2344 2352
11. M.K. Ito, R.L. Talbert, and S. Tsimikas Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction Pharmacotherapy 26 2006 85 97
12. R. Rossini, D. Capodanno, and C. Lettieri Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation Am J Cardiol 107 2011 186 194
13. M. Nishino, S. Hoshida, and H. Kato Preprocedural statin administration can reduce thrombotic reaction after stent implantation Circ J 72 2008 232 237
14. T. Palmerini, G. Dangas, and R. Mehran Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the acuity trial Circ Cardiovasc Interv 4 2011 577 584
15. G.D. Dangas, A. Caixeta, and R. Mehran Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
16. M. Schillinger, M. Exner, and W. Mlekusch Statin therapy improves cardiovascular outcome of patients with peripheral artery disease Eur Heart J 25 2004 742 748
17. R.J. Bisoendial, J.J. Kastelein, and J.H. Levels Activation of inflammation and coagulation after infusion of c-reactive protein in humans Circ Res 96 2005 714 716
18. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Clinical relevance of c-reactive protein during follow-up of patients with acute coronary syndromes in the aggrastat-to-zocor trial Circulation 114 2006 281 288
19. U. Schonbeck, and P. Libby Inflammation, immunity, and hmg-coa reductase inhibitors: statins as antiinflammatory agents? Circulation 109 2004 18 26
20. P.M. Ridker Clinical application of c-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
21. J.J. Smit, A.W. van 't Hof, and M.J. de Boer Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction Thromb Haemost 96 2006 190 195